Loading institutional data...
Loading institutional data...
Held by 613 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $20.76 today, the market must believe free cash flow compounds 6.0%/yr for a decade (off $774M normalized FCF).
The market's 6.0% is more optimistic than its 9-yr track record.
2-stage DCF · 0.55B shares · net debt $2.2B
mean -1.2% · volatility σ 24% · implied rate exceeded in 3/9 yrs
Central path = implied 6.0%/yr growth; shaded band = ±1σ (24%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (118%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $633M dividends + $0 buybacks = $633M returned on $534M FCF.
9 consecutive years of dividend increases · 8%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~2.7% on $2.9B of debt.
Cash of $671M fully covers short-term debt of $7M.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
No material risks flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 79.3 | 80.2 | 81.0 | 83.1 | 82.6 | 83.5 | 83.0 | 84.4 |
| Gross Profit | 20.7 | 19.8 | 19.0 | 16.9 | 17.4 | 16.5 | 17.0 | 15.6 |
| R&D | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| SG&A | 8.8 | 7.7 | 7.9 | 7.5 | 7.1 | 7.8 | 8.4 | 8.2 |
| Operating Income | 12.4 | 12.6 | 11.5 | 9.9 | 10.5 | 8.9 | 9.0 | 5.9 |
| Income Tax | 1.8 | 2.4 | 2.1 | 1.9 | 2.2 | 1.8 | 1.9 | 1.5 |
| Net Income | 10.6 | 10.3 | 9.5 | 8.0 | 8.0 | 6.6 | 6.8 | 4.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on HRL: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.11B 100.0% | $11.92B 100.0% | $12.11B 100.0% | $12.46B 100.0% | $11.39B 100.0% | $9.61B 100.0% | $9.50B 100.0% | $9.55B 100.0% | $9.17B 100.0% | $9.52B 100.0% |
| Cost of Revenue | $10.21B 84.4% | $9.90B 83.0% | $10.11B 83.5% | $10.29B 82.6% | $9.46B 83.1% | $7.78B 81.0% | $7.61B 80.2% | $7.57B 79.3% | $7.17B 78.2% | $7.37B 77.3% |
| Cost of Products | — | — | — | — | — | — | — | — | $7.16B 78.1% | $7.37B 77.3% |
| Gross Profit | $1.89B 15.6% | $2.02B 17.0% | $2.00B 16.5% | $2.16B 17.4% | $1.93B 16.9% | $1.83B 19.0% | $1.88B 19.8% | $1.98B 20.7% | $2.00B 21.8% | $2.16B 22.7% |
| Research & Development | $35.2M 0.3% | $36.1M 0.3% | $33.7M 0.3% | $34.7M 0.3% | $33.6M 0.3% | $31.9M 0.3% | $32.5M 0.3% | $33.8M 0.4% | $34.2M 0.4% | $34.7M 0.4% |
| Selling, General & Admin | $996.6M 8.2% | $1.01B 8.4% | $942.2M 7.8% | $879.3M 7.1% | $853.1M 7.5% | $761.3M 7.9% | $727.6M 7.7% | $841.2M 8.8% | $759.3M 8.3% | $872.0M 9.2% |
| Operating Income | $718.6M 5.9% | $1.07B 9.0% | $1.07B 8.9% | $1.31B 10.5% | $1.12B 9.9% | $1.10B 11.5% | $1.20B 12.6% | $1.18B 12.4% | $1.28B 13.9% | $1.32B 13.9% |
| Interest Expense | $78.0M 0.6% | $80.9M 0.7% | $73.4M 0.6% | $62.5M 0.5% | $43.3M 0.4% | $21.1M 0.2% | $18.1M 0.2% | $26.5M 0.3% | $12.7M 0.1% | $12.9M 0.1% |
| Other Income (Expense), net | $235.5M 1.9% | $215.3M 1.8% | $214.5M 1.8% | -$99.3M -0.8% | -$112.8M -1.0% | -$52.3M -0.5% | $31.5M 0.3% | $27.8M 0.3% | $14.6M 0.2% | $6.2M 0.1% |
| Pretax Income | $663.4M 5.5% | $1.04B 8.7% | $1.01B 8.4% | $1.28B 10.3% | $1.13B 9.9% | $1.11B 11.6% | $1.21B 12.7% | $1.18B 12.4% | $1.28B 13.9% | $1.32B 13.8% |
| Income Tax Expense | $185.7M 1.5% | $230.8M 1.9% | $220.6M 1.8% | $277.9M 2.2% | $217.0M 1.9% | $206.4M 2.1% | $230.6M 2.4% | $168.7M 1.8% | $431.5M 4.7% | $426.7M 4.5% |
| Net Income | $478.2M 4.0% | $805.0M 6.8% | $793.6M 6.6% | $1000.0M 8.0% | $908.8M 8.0% | $908.1M 9.5% | $978.8M 10.3% | $1.01B 10.6% | $846.7M 9.2% | $890.1M 9.3% |
| Per Share | ||||||||||
| EPS (Basic) | $0.87 | $1.47 | $1.45 | $1.84 | $1.68 | $1.69 | $1.83 | $1.91 | $1.60 | $1.68 |
| EPS (Diluted) | $0.87 | $1.47 | $1.45 | $1.82 | $1.66 | $1.66 | $1.80 | $1.86 | $1.57 | $1.64 |
| Weighted Avg Shares (Basic) | 550.2M | 548.1M | 546.4M | 544.9M | 541.1M | 538.0M | 534.6M | 530.7M | 528.4M | 529.3M |
| Weighted Avg Shares (Diluted) | 550.5M | 548.8M | 549.0M | 549.6M | 547.6M | 546.6M | 545.2M | 543.9M | 539.1M | 542.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $858.2B | 39.4× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.1B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.1B | 28.9× | 24.8× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $345.5B | 22.6× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $298.3B | 26.4× | 17.4× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.9B | 22.4× | 15.0× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $117.4B | 17.0× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.7B | 33.0× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $70.0B | 19.0× | 10.2× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $69.7B | 33.1× | 19.4× | 3.4× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.6B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $43.2B | 20.8× | 14.5× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| FMX | $41.2B | — | — | — | — | — | — | — | — | — | 290 |
| ADM | $41.1B | 38.1× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| JBS | $40.2B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.9B | 39.7× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.4B | 21.1× | 9.6× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| HSY | $34.6B | — | 20.3× | 3.0× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $34.4B | — | 782.5× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KVUE | $34.2B | 23.5× | 11.6× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.1B | 18.0× | 8.0× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.2B | 31.6× | 18.9× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
| HRL | $11.4B | 23.9× | 13.9× | 0.9× | 1.6% | 15.6% | 4.0% | 6.1% | 4.4% | 2.9× | 613 |
Peers = companies sharing HRL's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.